Catalyst Pharmaceuticals, Inc. (CPRX)
24.79
+0.10
(+0.41%)
USD |
NASDAQ |
Apr 06, 10:26
Catalyst Pharmaceuticals SG&A Expense (TTM) : 171.18M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 96.42M |
| ANI Pharmaceuticals, Inc. | 317.74M |
| Inovio Pharmaceuticals, Inc. | 32.68M |
| Indivior Pharmaceuticals, Inc. | 635.00M |
| United Therapeutics Corp. | 645.00M |